explore -WSS

explore

author：leisure time 2025-10-01 14:20:00 - browse：86

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of independent advisers to the Food and Drug Administration voted overwhelmingly against a polarizing potential treatment for ALS on Wednesday, concluding that the medicine’s messy supporting data did not meet the standard for approval.

After a day-long meeting that included impassioned testimony from ALS patients, the agency’s expert advisers voted 17-1 with one abstention that the case for NurOwn, a treatment from BrainStorm Cell Therapeutics, was based too heavily on convoluted clinical trial results and compelling but unreliable anecdotal evidence.

“Patients and families need hope, but providing false hope can be ethically problematic,” said panelist Lisa Lee, a bioethicist at Virginia Tech. “False hope is provided when the probability of a positive outcome is overestimated, and I think that seems to be the case here.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： It's time to take a new tack for treating Alzheimer's

entertainment

WSS

Nearly two

Hey, doctors: Don't be no

Humana, CVS hope to turn members into patients at clinics

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

What Henrietta Lacks settlement says about racism in medicine

White House drug shortage group privately met with industry

focus

explore

explore

Heart attack and stroke risk calculators need revising

Dramatically reducing cancer deaths requires the PASTEUR Act

Alkermes shareholders re

What is the Turing Test that determines if computers can think?

Trump demands the U.S. pay no more for drugs than other countries … again

TytoCare raises $49 million to build out AI

United colonoscopy coverage change 'may cost lives,' doctors say

EMA weighs against approval for Mirati's lung cancer drug

The high cost of giving birth even with insurance

Verily hires former Apple Health leader as chief scientific officer

hotspot

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

It's time to take a new tack for treating Alzheimer's

Hey, doctors: Don't be no

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

Pfizer's RSV vaccine recommended for approval in Europe

hotspot

hotspot

entertainment

leisure time